24rd June 2022 | Pharma Updates
Holistic practitioners displeased with National Medical Commission's draft conduct rules
Doctors who practice holistic medicine have fiercely resisted a provision in the draught regulations released by the National Medical Commission addressing the professional behaviour of medical practitioners.
SARS-CoV-2 omicron subvariants "significantly" evade neutralising antibodies
SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5 “significantly” avoided neutralizing antibodies elicited by both vaccination and infection, as per research results published in The New England Journal of Medicine.
Glenmark Baddi Facility receives 6 observations from USFDA
Following an examination at formulation manufacturing plant of Glenmark Pharmaceuticals, which is based out of Baddi in Himachal Pradesh, between June 13 and June 22, 2022, the USFDA issued Form 483 with six observations.
Pfizer plans to end the blinding illness trachoma by 2030
Pfizer announced that it would extend until 2030 a medicine donation program intended to eradicate trachoma, an eye illness that has rendered over two million people globally blind or visually impaired.
Dr. Reddy's Laboratories intends to use mergers and acquisitions to advance
Dr. Reddy’s Laboratories stated it’s goal will be largely achieved through brand and company mergers and acquisitions, in-licensing agreements targeting chronic categories, and portfolio expansion in the nutraceutical and over-the-counter (OTC) markets.
Top cybersecurity issues for global & Indian pharma
Cybersecurity concerns for Indian pharma firms as they make the digital jump are ransomware attacks and IP and data theft. Some pharma corporations have increased their investments in cybersecurity as a result of an increase in targeted attacks.
Johnson & Johnson will continue to manufacture COVID vaccines at Biological-E
Children between the ages of 12 and 14 are currently being immunised with Biological E’s Corbevax, India’s first RBD protein subunit vaccine. For people 18 years of age and above, DCGI recently approved Corbevax as precautionary dose.